Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV
Tài liệu tham khảo
Pallikkuth, 2015, Peripheral T follicular helper cells are the major HIV reservoir within central memory CD4 T cells in peripheral blood from chronically HIV-infected individuals on combination antiretroviral therapy, J Virol, 90, 2718, 10.1128/JVI.02883-15
Henderson, 2020, Advances toward curing HIV-1 infection in tissue reservoirs, J Virol, 94, 10.1128/JVI.00375-19
Banga, 2021, HIV persistence in lymph nodes, Curr Opin HIV AIDS, 16, 209, 10.1097/COH.0000000000000686
Cohn, 2020, The biology of the HIV-1 latent reservoir and implications for cure strategies, Cell HostMicrobe, 27, 519
Mohamed, 2020, The evolution of dendritic cell immunotherapy against HIV-1 infection: improvements and outlook, J ImmunolRes, 2020
Deeks, 2012, HIV: shock and kill, Nature, 487, 439, 10.1038/487439a
Shan, 2017, Transcriptional reprogramming during effector-to-memory transition renders CD4(+) T cells permissive for latent HIV-1 infection, Immunity, 47, 766, 10.1016/j.immuni.2017.09.014
Martinez-Picado, 2016, Persistent HIV-1 replication during antiretroviral therapy, Curr Opin HIV AIDS, 11, 417, 10.1097/COH.0000000000000287
Walker-Sperling, 2015, Reactivation kinetics of HIV-1 and susceptibility of reactivated latently infected CD4+ T cells to HIV-1-specific CD8+ T cells, J Virol, 89, 9631, 10.1128/JVI.01454-15
O'Connell, 2009, Elucidating the elite: mechanisms of control in HIV-1 infection, Trends Pharmacol Sci, 30, 631, 10.1016/j.tips.2009.09.005
Pantaleo, 2016, Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change, Curr Opin HIV AIDS, 11, 576, 10.1097/COH.0000000000000324
Bekerman, 2019, PD-1 blockade and TLR7 activation lack therapeutic benefit in chronic simian immunodeficiency virus-infected macaques on antiretroviral therapy, Antimicrob Agents Chemother, 63, 10.1128/AAC.01163-19
Seddiki, 2018, Therapeutic HIV-1 vaccine: time for immunomodulation and combinatorial strategies, Curr Opin HIV AIDS., 13, 119, 10.1097/COH.0000000000000444
Martin-Gayo, 2015, Potent cell-intrinsic immune responses in dendritic cells facilitate HIV-1-specific T cell immunity in HIV-1 elite controllers, PLoS Pathog, 11, 10.1371/journal.ppat.1004930
Martin-Gayo, 2018, A reproducibility-based computational framework identifies an inducible, enhanced antiviral state in dendritic cells from HIV-1 elite controllers, Genome Biol, 19, 10, 10.1186/s13059-017-1385-x
Decout, 2021, The cGAS-STING pathway as a therapeutic target in inflammatory diseases, Nat Rev Immunol, 21, 548, 10.1038/s41577-021-00524-z
Calvet-Mirabent, 2021, Poly I:C and STING agonist-primed DC increase lymphoid tissue polyfunctional HIV-1-specific CD8(+) T cells and limit CD4(+) T-cell loss in BLT mice, Eur J Immunol
Kristoff, 2019, Role of dendritic cells in exposing latent HIV-1 for the kill, Viruses, 12, 10.3390/v12010037
Kristoff, 2019, Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1, EBioMedicine, 43, 295, 10.1016/j.ebiom.2019.03.077
Kahan, 2015, T cell exhaustion during persistent viral infections, Virology, 479-480, 180, 10.1016/j.virol.2014.12.033
Kinloch-de Loes, 2004, Role of therapeutic vaccines in the control of HIV-1, J Antimicrob Chemother, 53, 562, 10.1093/jac/dkh132
Fenwick, 2019, T-cell exhaustion in HIV infection, Immunol Rev, 292, 149, 10.1111/imr.12823
Sharpe, 2018, The diverse functions of the PD1 inhibitory pathway, Nat Rev Immunol, 18, 153, 10.1038/nri.2017.108
Reiser, 2016, Memory, and dysfunctional CD8(+) T cell fates in the antitumor immune response, J ImmunolRes, 2016
Kallies, 2020, Precursor exhausted T cells: key to successful immunotherapy?, Nat Rev Immunol, 20, 128, 10.1038/s41577-019-0223-7
Bengsch, 2016, Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion, Immunity, 45, 358, 10.1016/j.immuni.2016.07.008
He, 2017, CD155T/TIGIT signaling regulates CD8(+) T-cell metabolism and promotes tumor progression in human gastric cancer, Cancer Res, 77, 6375, 10.1158/0008-5472.CAN-17-0381
Lee, 2020, Association of TIM-3 expression with glucose metabolism in Jurkat T cells, BMC Immunol, 21, 48, 10.1186/s12865-020-00377-6
Jones, 2017, Metabolic adaptation of human CD4(+) and CD8(+) T-cells to t-cell receptor-mediated stimulation, Front Immunol, 8, 1516, 10.3389/fimmu.2017.01516
Ma, 2017, Serine is an essential metabolite for effector T cell expansion, Cell Metab, 25, 345, 10.1016/j.cmet.2016.12.011
Guo, 2021, Metabolic reprogramming of terminally exhausted CD8(+) T cells by IL-10 enhances anti-tumor immunity, Nat Immunol, 22, 746, 10.1038/s41590-021-00940-2
Angin, 2019, Metabolic plasticity of HIV-specific CD8(+) T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection, NatMetabol, 1, 704
Day, 2021, Targeting mitochondria to beat HIV-1, Nat Immunol, 22, 398, 10.1038/s41590-021-00881-w
Martin, 2018, Post-treatment and spontaneous HIV control, Curr Opin HIV AIDS., 13, 402, 10.1097/COH.0000000000000488
Sáez-Cirión, 2013, Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study, PLoS Pathog, 9, 10.1371/journal.ppat.1003211
Horiuchi, 2017, Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity, J Biol Chem, 292, 8436, 10.1074/jbc.M116.769380
Li, 2018, Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer, Cancer Res, 78, 1779, 10.1158/0008-5472.CAN-17-2460
Zhang, 2020, Metformin enhances the antitumor activity of CD8(+) T lymphocytes via the AMPK-miR-107-eomes-PD-1 pathway, J Immunol, 204, 2575, 10.4049/jimmunol.1901213
Singhal, 2014, Metformin as adjunct antituberculosis therapy, Sci Transl Med, 6, 10.1126/scitranslmed.3009885
Ruiz, 2018, Antigen production after latency reversal and expression of inhibitory receptors in CD8+ T cells limit the killing of HIV-1 reactivated cells, Front Immunol, 9, 3162, 10.3389/fimmu.2018.03162
Phan, 2016, Constitutive glycolytic metabolism supports CD8(+) T cell effector memory differentiation during viral infection, Immunity, 45, 1024, 10.1016/j.immuni.2016.10.017
Cheng, 2018, TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs, J Clin Invest, 128, 4387, 10.1172/JCI99005
Smith, 2016, Effective cytotoxic T lymphocyte targeting of persistent HIV-1 during antiretroviral therapy requires priming of naive CD8+ T cells, mBio, 7, 10.1128/mBio.00473-16
Coffman, 2010, Vaccine adjuvants: putting innate immunity to work, Immunity, 33, 492, 10.1016/j.immuni.2010.10.002
Poteet, 2015, A novel prime and boost regimen of HIV virus-like particles with TLR4 adjuvant MPLA induces Th1 oriented immune responses against HIV, PLoS One, 10, 10.1371/journal.pone.0136862
Phillips, 2018, Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant Rhesus Macaques, J Virol, 92, 10.1128/JVI.01051-18
Kasturi, 2020, 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates, Sci Immunol, 5, 10.1126/sciimmunol.abb1025
Borducchi, 2018, Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys, Nature, 563, 360, 10.1038/s41586-018-0600-6
Liang, 2017, Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake, Sci Transl Med, 9, 10.1126/scitranslmed.aal2094
Plana, 2000, Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection, AIDS, 14, 1921, 10.1097/00002030-200009080-00007
Korencak, 2019, Effect of HIV infection and antiretroviral therapy on immune cellular functions, JCI Insight, 4, 10.1172/jci.insight.126675
Sáez-Cirión, 2021, Immunometabolism and HIV-1 pathogenesis: food for thought, Nat Rev Immunol, 21, 5, 10.1038/s41577-020-0381-7
Martin-Gayo, 2017, Dendritic cell immune responses in HIV-1 controllers, Curr HIV/AIDS Rep, 14, 1, 10.1007/s11904-017-0345-0
Boppana, 2018, 7
Velu, 2009, Enhancing SIV-specific immunity in vivo by PD-1 blockade, Nature, 458, 206, 10.1038/nature07662
Mylvaganam, 2018, Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV, JCI Insight, 3, 10.1172/jci.insight.122940
Etemad, 2019, Learning from the exceptions: HIV remission in post-treatment controllers, Front Immunol, 10, 1749, 10.3389/fimmu.2019.01749
McMahon, 2021, Viral, inflammatory, and reservoir characteristics of posttreatment controllers, Curr Opin HIV AIDS., 16, 249, 10.1097/COH.0000000000000699
Perdomo-Celis, 2019, An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression, PLoS One, 14, 10.1371/journal.pone.0210540
Buzon, 2014, Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells, J Virol, 88, 10056, 10.1128/JVI.01046-14
Keating, 2019, Brief report: HIV antibodies decline during antiretroviral therapy but remain correlated with HIV DNA and HIV-specific T-cell responses, J Acquir Immune Defic Syndr, 81, 594, 10.1097/QAI.0000000000002080
Morvan, 2021, The CD8(+) T cell noncytotoxic antiviral responses, Microbiol Mol Biol Rev, 85, 10.1128/MMBR.00155-20
Jin, 2020, Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition, Cell MolImmunol, 17, 1257
Le Bert, 2020, Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection, Gastroenterology, 159, 652, 10.1053/j.gastro.2020.04.019
Collins, 2021, Functional impairment of HIV-specific CD8(+) T cells precedes aborted spontaneous control of viremia, Immunity, 54, 2372, 10.1016/j.immuni.2021.08.007
Banga, 2019, Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement, PLoS Pathog, 15, 10.1371/journal.ppat.1007918
Sperk, 2018, Immune checkpoints as the immune system regulators and potential biomarkers in HIV-1 infection, Int J Mol Sci, 19, 10.3390/ijms19072000
Tang, 2019, Tim-3: a co-receptor with diverse roles in T cell exhaustion and tolerance, Semin Immunol, 42, 10.1016/j.smim.2019.101302
Hudson, 2019, Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1(+) stem-like CD8(+) T cells during chronic infection, Immunity, 51, 1043, 10.1016/j.immuni.2019.11.002
Liu, 2020, Study on Tim3 regulation of multiple myeloma cell proliferation via NF-κB signal pathways, Front Oncol, 10, 10.3389/fonc.2020.584530
Mehraj, 2015, Tryptophan catabolism in chronic viral infections: handling uninvited guests, Int J TryptophanRes: IJTR, 8, 41
Chen, 2019, Plasma Indoleamine 2,3-dioxygenase activity is associated with the size of the human immunodeficiency virus reservoir in patients receiving antiretroviral therapy, Clin Infect Dis, 68, 1274, 10.1093/cid/ciy676
Salminen, 2021, Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases, J Mol Med, 99, 1, 10.1007/s00109-020-01988-7
Ogbechi, 2020, IDO activation, inflammation and musculoskeletal disease, Exp Gerontol, 131, 10.1016/j.exger.2019.110820
Rahman, 2021, Elevated glycolysis imparts functional ability to CD8(+) T cells in HIV infection, Life SciAlliance, 4
Shytaj, 2021, Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress, EMBO Mol Med, 13, e13901, 10.15252/emmm.202013901
Utzschneider, 2016, T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections, Immunity, 45, 415, 10.1016/j.immuni.2016.07.021
Liesa, 2016, Mitochondrial networking in T cell memory, Cell, 166, 9, 10.1016/j.cell.2016.06.035
Buck, 2016, Mitochondrial dynamics controls T cell fate through metabolic programming, Cell, 166, 63, 10.1016/j.cell.2016.05.035
Cao, 2016, Early initiation rather than prolonged duration of antiretroviral therapy in HIV infection contributes to the normalization of CD8 T-cell counts, Clin Infect Dis, 62, 250, 10.1093/cid/civ809
Gálvez, 2020, Extremely low viral reservoir in treated chronically HIV-1-infected individuals, EBioMedicine, 57, 10.1016/j.ebiom.2020.102830
Warren, 2019, Harnessing CD8(+) T cells under HIV antiretroviral therapy, Front Immunol, 10, 291, 10.3389/fimmu.2019.00291
Martin-Cofreces, 2020, The chaperonin CCT controls T cell receptor-driven 3D configuration of centrioles, Sci Adv, 6, 10.1126/sciadv.abb7242